Angiogenesis; Antiangiogenic Role of 2ME2 Demonstrated in Rheumatoid Arthritis Models

| Ask | Become a Library member

Angiogenesis; Antiangiogenic Role of 2ME2 Demonstrated in Rheumatoid Arthritis Models

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_205175764

Angiogenesis; Antiangiogenic Role of 2ME2 Demonstrated in Rheumatoid Arthritis Models

About this item

Full title

Angiogenesis; Antiangiogenic Role of 2ME2 Demonstrated in Rheumatoid Arthritis Models

Publisher

Atlanta: NewsRx

Journal title

Angiogenesis Weekly, 2008, p.6

Language

English

Formats

Newsletter articles

Publication information

Publisher

Atlanta: NewsRx

Subjects

Subjects and topics

Brahn, Ernest

More information

Scope and Contents

Contents

2008 NOV 21 - ( NewsRx.com) -- EntreMed, Inc. (NASDAQ:ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced the publication of preclinical results for 2ME2 (Panzem(R) or 2- methoxyestradiol) in rheumatoid arthritis (RA). The results of the study...

Alternative Titles

Full title

Angiogenesis; Antiangiogenic Role of 2ME2 Demonstrated in Rheumatoid Arthritis Models

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_205175764

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_205175764

Other Identifiers

ISSN

1531-6416

E-ISSN

1531-6904

How to access this item

Log in as a Library member

Full text available

View in old catalogue

Connecting people and collections

Indigenous engagement

Celebrating and sharing stories of Indigenous Australia, and helping to locate and prioritise Indigenous voices in the Library's collections.

Learning

Resources and programs for school and university students, teachers, families and lifelong learners.

Stories

Showcasing people, places and ideas inspired by the collection and the library community.